Stay updated on SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial

Sign up to get notified when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a technical site update rather than a change to the trial’s published content.
    Difference
    0.1%
    Check dated 2026-04-24T16:45:45.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:39:11.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed, indicating a site version update.
    Difference
    0.1%
    Check dated 2026-03-19T20:57:44.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated: v3.4.3 added and v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-12T20:13:46.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 instead of v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:54:50.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The new screenshot shows an updated revision label: v3.4.1 replaces v3.4.0. No substantive changes to study details, eligibility criteria, outcomes, or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:55:06.000Z thumbnail image

Stay in the know with updates to SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.